Subscribe to RSS - diabetes supplies

diabetes supplies

Mini Pharmacy sells to PE firm

 - 
06/12/2019

LOS ANGELES – Mini Pharmacy, a pharmacy specializing in providing diabetic supplies primarily to the California market, is now owned by Angeles Equity Partners. Mini was founded in 1980 and has been led by the Fox family.

Solara makes second buy since investment

 - 
12/06/2018

CHULA VISTA, Calif. – Solara Medical Supplies, a provider of diabetes devices, has acquired Illinois-based Huey’s Home Medical.

Website launches for discount diabetes supplies

 - 
10/03/2018

ELMHURST, N.Y. – Affordable OTC, a provider of discount diabetes products, has launched https://affordableotc.com, a website that offers products with savings of more than 70%.

Solara Medical Supplies receives PE investment

 - 
06/07/2018

CHULA VISTA, Calif. – Solara Medical Supplies has received an investment from Linden Capital Partners, a Chicago-based healthcare private equity firm.

AADE releases tip sheet for mail-order diabetes program

 - 
04/03/2018

CHICAGO – The American Association of Diabetes Educators has released a tip sheet for navigating Medicare’s national

Embattled Arriva Medical closes

 - 
11/07/2017

CORAL SPRINGS and BOCA RATON, Fla. – Arriva Medical is closing its facility in Coral Springs and laying off 142 employees, the Sun Sentinel reports.

Bill seeks to strengthen protections for diabetes patients

 - 
10/10/2017

WASHINGTON – Sens. Mark Warner, D-Va., and Tim Scott, R-S.C., have introduced a bill to strengthen the patient protections that are part of Medicare’s national mail-order program for diabetes testing supplies.

Diabetes supplies en route to Texas

 - 
08/30/2017

ARLINGTON, Va. – The American Diabetes Association, JDRF and Insulin for Life have secured and shipped more than 3,750 pounds of donated diabetes supplies to people with diabetes affected by Hurricane Harvey, they announced Aug. 29.

Dexcom ships G5 to Medicare beneficiaries

 - 
08/25/2017

SAN DIEGO – Dexcom has begun shipping the Dexcom G5 to Medicare beneficiaries who meet coverage requirements for continuous glucose monitoring, according to news reports. CMS in January classified “therapeutic” CGMs as DME, paving the way for coverage if certain criteria are met. In July, Dexcom reached an agreement with Ascensia Diabetes Care to bundle Ascensia’s ContourNext One glucose monitoring system with the G5. CMS has set a one-time fee of $236 to $277 for the CGM receiver, and a monthly allowable of $248.38 for related accessories. Demand for the G5 is so high that 20,000 beneficiaries are “in the pipeline” for a device. The G5 is currently the only CGM approved for insulin dosing.

DarioHealth enters strategic agreement with Byram

 - 
07/26/2017

CAESAREA, Israel, and NEW YORK – DarioHealth has expanded its insurance coverage provider network by entering into a strategic agreement with Byram Healthcare, the two companies announced July 25.

Pages